Artículos de revistas sobre el tema "Lung and breast/ovarian cancer"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Lung and breast/ovarian cancer".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Prat, Aleix, Barbara Adamo, Cheng Fan, Maria Vidal, Patricia Galvan, Enriqueta Felip, Jose Maria Del Campo, Josep Tabernero y Javier Cortes. "Molecular identification of basal-like breast cancer through genomic analyses across five cancer types." Journal of Clinical Oncology 31, n.º 15_suppl (20 de mayo de 2013): 1011. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.1011.
Texto completoAchariyapota, Vuthinun, Tuenjai Chuangsuwanich y Mongkol Benjapibal. "Inflammatory Breast Cancer from Metastatic Ovarian Cancer". Case Reports in Obstetrics and Gynecology 2016 (2016): 1–3. http://dx.doi.org/10.1155/2016/3476143.
Texto completoR., Abhirup H., Priyanka Kenchetty y Aishwarya K. Chidananda. "Breast ovarian cancer syndrome". International Surgery Journal 8, n.º 8 (28 de julio de 2021): 2454. http://dx.doi.org/10.18203/2349-2902.isj20213144.
Texto completoAbu-Tineh, Mohammad, Hind Elmalik y Mohamed A. Yassin. "Metastatic Ovarian Cancer Presenting as Inflammatory Breast Cancer: A Case Report". Case Reports in Oncology 13, n.º 2 (28 de julio de 2020): 867–74. http://dx.doi.org/10.1159/000508358.
Texto completoBacalbasa, Nicolae, Irina Balescu, Claudia Stoica, Cristina Martac, Valentin Varlas, Andrei Voichitoiu, Lucian Pop, Sorin Petrea, Mihaela Vilcu y Iulian Brezean. "Breast metastases from ovarian cancer". Romanian Medical Journal 69, S4 (20 de junio de 2022): 14–16. http://dx.doi.org/10.37897/rmj.2022.s4.3.
Texto completoArora, Nimisha, Aline Talhouk, Jessica N. McAlpine, Michael R. Law y Gillian E. Hanley. "Causes of death among women with epithelial ovarian cancer by length of survival post-diagnosis: a population-based study in British Columbia, Canada". International Journal of Gynecologic Cancer 29, n.º 3 (21 de diciembre de 2018): 593–98. http://dx.doi.org/10.1136/ijgc-2018-000040.
Texto completoHaan, David, Anna Bergamaschi, Yuhong Ning, William Gibb, Michael Kesling, Adriana Pitea, Maryam Nabiyouni et al. "Genome-wide 5hmC profiles to enable cancer detection and tissue of origin classification in breast, colorectal, lung, ovarian, and pancreatic cancers." Journal of Clinical Oncology 39, n.º 15_suppl (20 de mayo de 2021): 3044. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.3044.
Texto completoTkaczuk, Katherine R., Paula Rosenblatt, Ranee Mehra, Katherine A. Scilla, Nancy Tait, Katerra Caple, Binbin Yue y Ginette Serrero. "Abstract CT240: On-going phase 1A clinical trial for AG01 an first-in-class anti-progranulin (GP88) monoclonal antibody in patients with advanced malignancies". Cancer Research 83, n.º 8_Supplement (14 de abril de 2023): CT240. http://dx.doi.org/10.1158/1538-7445.am2023-ct240.
Texto completoRoland, Adjoby Cassou, Kouamé Arthur Didier, Koffi Achille, Kakou Charles, Konan Joachim, Andriamandimbison Zoly, Ahounkeng Patrick y Nshimirimana Eric. "Metastatic ovarian tumor of a lung cancer at the hospital center of Chauny (France): a case report". International Journal of Reproduction, Contraception, Obstetrics and Gynecology 6, n.º 10 (23 de septiembre de 2017): 4682. http://dx.doi.org/10.18203/2320-1770.ijrcog20174464.
Texto completoYurkovetsky, Zoya, Steven Skates, Aleksey Lomakin, Brian Nolen, Trenton Pulsipher, Francesmary Modugno, Jeffrey Marks et al. "Development of a Multimarker Assay for Early Detection of Ovarian Cancer". Journal of Clinical Oncology 28, n.º 13 (1 de mayo de 2010): 2159–66. http://dx.doi.org/10.1200/jco.2008.19.2484.
Texto completoTkaczuk, Katherine, Paula Rosenblatt, Ranee Mehra, Katherine Scilla, Nancy Tait, Binbin Yue y Ginette Serrero. "Abstract PO5-18-06: On-going phase 1A clinical trial of A01, a chimerized monoclonal antibody to Progranulin/Glycoprotein 88 (GP88) in patients with advanced malignancy". Cancer Research 84, n.º 9_Supplement (2 de mayo de 2024): PO5–18–06—PO5–18–06. http://dx.doi.org/10.1158/1538-7445.sabcs23-po5-18-06.
Texto completoCovic, Lidija y Athan Kuliopulos. "Protease-Activated Receptor 1 as Therapeutic Target in Breast, Lung, and Ovarian Cancer: Pepducin Approach". International Journal of Molecular Sciences 19, n.º 8 (31 de julio de 2018): 2237. http://dx.doi.org/10.3390/ijms19082237.
Texto completoO'Shannessy, Daniel J., Darren W. Davis, Kenna Anderes y Elizabeth B. Somers. "Isolation of Circulating Tumor Cells from Multiple Epithelial Cancers with ApoStream® for Detecting (or Monitoring) the Expression of Folate Receptor Alpha". Biomarker Insights 11 (enero de 2016): BMI.S35075. http://dx.doi.org/10.4137/bmi.s35075.
Texto completoSaad, Hebatallah M., Ghada F. Tourky, Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Ahmed M. Khattab, Sohaila A. Elmasry, Abdulrahman A. Alsayegh et al. "The Potential Role of MUC16 (CA125) Biomarker in Lung Cancer: A Magic Biomarker but with Adversity". Diagnostics 12, n.º 12 (29 de noviembre de 2022): 2985. http://dx.doi.org/10.3390/diagnostics12122985.
Texto completoBodogai, Monica, Purevdorj Olkhanud, Yrina Rochman, Enkhzol Malchinkhuu, Katarzyna Wejksza, Ronald Gress, Charles Hesdorffer, Warren Leonard y Arya Biragyn. "Thymic stromal lymphopoietin mediates breast cancer progression and metastasis (48.9)". Journal of Immunology 186, n.º 1_Supplement (1 de abril de 2011): 48.9. http://dx.doi.org/10.4049/jimmunol.186.supp.48.9.
Texto completoKarim, Md Adnan, Abdus Samad, Utpal Kumar Adhikari, Md Ashraful Kader, Md Masnoon Kabir, Md Aminul Islam y Md Nazmul Hasan. "A Multi-Omics Analysis of Bone Morphogenetic Protein 5 (BMP5) mRNA Expression and Clinical Prognostic Outcomes in Different Cancers Using Bioinformatics Approaches". Biomedicines 8, n.º 2 (21 de enero de 2020): 19. http://dx.doi.org/10.3390/biomedicines8020019.
Texto completoPinheiro, Céline, Rui M. Reis, Sara Ricardo, Adhemar Longatto-Filho, Fernando Schmitt y Fátima Baltazar. "Expression of Monocarboxylate Transporters 1, 2, and 4 in Human Tumours and Their Association with CD147 and CD44". Journal of Biomedicine and Biotechnology 2010 (2010): 1–7. http://dx.doi.org/10.1155/2010/427694.
Texto completoWeiss, Jessica M., Muhammad Danyal Ahsan, Emily M. Webster, Sarah R. Levi, Murtaza Qazi, Benedict Harvey, Evelyn Cantillo et al. "Hereditary breast and ovarian cancer syndrome: A misnomer?" Journal of Clinical Oncology 41, n.º 16_suppl (1 de junio de 2023): 10594. http://dx.doi.org/10.1200/jco.2023.41.16_suppl.10594.
Texto completoArason, Agnarsson, Johannesdottir, Johannsson, Hilmarsdottir, Reynisdottir y Barkardottir. "The BRCA1 c.4096+3A>G Variant Displays Classical Characteristics of Pathogenic BRCA1 Mutations in Hereditary Breast and Ovarian Cancers, But Still Allows Homozygous Viability". Genes 10, n.º 11 (1 de noviembre de 2019): 882. http://dx.doi.org/10.3390/genes10110882.
Texto completoErickson-Miller, Connie L., Jennifer Kirchner, Kodandaram Pillarisetti, Lone Ottesen, Yasser Mostafa Kamel, Yuan Liu, Anne-Marie Martin y Conrad Messam. "Eltrombopag Decreases Proliferation of Ovarian, Lung and Breast Tumor Cell Lines." Blood 114, n.º 22 (20 de noviembre de 2009): 2409. http://dx.doi.org/10.1182/blood.v114.22.2409.2409.
Texto completoBenti, Senyi, Purushottam B. Tiwari, Dustin W. Goodlett, Leily Daneshian, Grant B. Kern, Mark D. Smith, Aykut Uren, Maksymilian Chruszcz, Linda S. Shimizu y Geeta Upadhyay. "Small Molecule Binds with Lymphocyte Antigen 6K to Induce Cancer Cell Death". Cancers 12, n.º 2 (22 de febrero de 2020): 509. http://dx.doi.org/10.3390/cancers12020509.
Texto completoCalaf, Gloria M., Leodan A. Crispin, Juan P. Muñoz, Francisco Aguayo y Tammy C. Bleak. "Muscarinic Receptors Associated with Cancer". Cancers 14, n.º 9 (7 de mayo de 2022): 2322. http://dx.doi.org/10.3390/cancers14092322.
Texto completoFerreira, Thamara, Thais Ferreira Bomfim-Palma, Isabelle Joyce de Lima Silva-Fernandes, Gabriela Espirito Santo Felix, Inacelli Queiroz De Souza Caires, Leandro Apolinário Silva, Luciana Garcia Landeiro et al. "PALB2 mutations in Brazilian patients from North-Northeast regions." Journal of Clinical Oncology 38, n.º 15_suppl (20 de mayo de 2020): e13670-e13670. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e13670.
Texto completoDUPONT, J., C. AGHAJANIAN, P. SABBATINI y D. R. SPRIGGS. "New agents for the treatment of ovarian cancer: the next generation". International Journal of Gynecologic Cancer 15, Suppl 3 (noviembre de 2005): 252–57. http://dx.doi.org/10.1136/ijgc-00009577-200511001-00012.
Texto completoMuggia, Franco M. "Significant developments in ovarian, breast and lung cancer therapy". Inpharma Weekly &NA;, n.º 994 (julio de 1995): 3–5. http://dx.doi.org/10.2165/00128413-199509940-00002.
Texto completoBrown, Geoffrey. "Deregulation of All-Trans Retinoic Acid Signaling and Development in Cancer". International Journal of Molecular Sciences 24, n.º 15 (28 de julio de 2023): 12089. http://dx.doi.org/10.3390/ijms241512089.
Texto completoCole, Alexander P., Chang Lu, Marieke J. Krimphove, Julie Szymaniak, Maxine Sun, Sean A. Fletcher, Stuart R. Lipsitz et al. "Comparing the Association Between Insurance and Mortality in Ovarian, Pancreatic, Lung, Colorectal, Prostate, and Breast Cancers". Journal of the National Comprehensive Cancer Network 17, n.º 9 (septiembre de 2019): 1049–58. http://dx.doi.org/10.6004/jnccn.2019.7296.
Texto completoSolomon, Benjamin Maurice, Kari G. Rabe, Susan L. Slager, Jerry D. Brewer, James R. Cerhan y Tait D. Shanafelt. "Overall and cancer-specific survival of breast, colon, and lung cancer in patients with and without chronic lymphocytic leukemia: A SEER population-based study of over 1 million patients." Journal of Clinical Oncology 30, n.º 15_suppl (20 de mayo de 2012): 6571. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.6571.
Texto completoLawler, Thomas y Shaneda Warren Andersen. "Serum 25-Hydroxyvitamin D and Cancer Risk: A Systematic Review of Mendelian Randomization Studies". Nutrients 15, n.º 2 (13 de enero de 2023): 422. http://dx.doi.org/10.3390/nu15020422.
Texto completoGuo, Maoni y San Ming Wang. "The BRCAness Landscape of Cancer". Cells 11, n.º 23 (1 de diciembre de 2022): 3877. http://dx.doi.org/10.3390/cells11233877.
Texto completoCheng, En, Donghoon Lee, Rulla M. Tamimi, Susan Hankinson, Walter C. Willett, Edward L. Giovannucci, Heather Eliassen et al. "Long-term cancer survival in cohorts of U.S. health professionals." Journal of Clinical Oncology 38, n.º 15_suppl (20 de mayo de 2020): 12075. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.12075.
Texto completoTourassi, Georgia, Hong-Jun Yoon, Songhua Xu y Xuesong Han. "The utility of web mining for epidemiological research: studying the association between parity and cancer risk". Journal of the American Medical Informatics Association 23, n.º 3 (27 de noviembre de 2015): 588–95. http://dx.doi.org/10.1093/jamia/ocv141.
Texto completoLuo, Huiyan, Pansong Li, Wei Wei, Yong-Bin Lin, Hong Yang, Han Yang, Kong-Jia Luo et al. "High-sensitive multi-cancers early detection for 8 cancer types by cell-free DNA targeted methylation sequencing: A retrospective cohort study." Journal of Clinical Oncology 42, n.º 16_suppl (1 de junio de 2024): 3043. http://dx.doi.org/10.1200/jco.2024.42.16_suppl.3043.
Texto completoOlea-Flores, Monserrat, Juan C. Juárez-Cruz, Miriam D. Zuñiga-Eulogio, Erika Acosta, Eduardo García-Rodríguez, Ana E. Zacapala-Gomez, Miguel A. Mendoza-Catalán, Julio Ortiz-Ortiz, Carlos Ortuño-Pineda y Napoleón Navarro-Tito. "New Actors Driving the Epithelial–Mesenchymal Transition in Cancer: The Role of Leptin". Biomolecules 10, n.º 12 (15 de diciembre de 2020): 1676. http://dx.doi.org/10.3390/biom10121676.
Texto completoBacalbasa, N., A. Traistaru y I. Balescu. "OVARIAN METASTATIC TUMORS – A LITERATURE REVIEW". Romanian Medical Journal 62, n.º 2 (30 de junio de 2015): 115–18. http://dx.doi.org/10.37897/rmj.2015.2.6.
Texto completoAdeboyeje, Gboyega, Eleanor O. Caplan, Yihua Xu, Monica Chase, Sheetal Sheth, Brandon T. Suehs y Nicole Myer. "Abstract 4111: Trends in the use of broad genomic sequencing-directed therapy among Medicare patients with newly diagnosed advanced cancer in the United States from 2018-2020: A retrospective analysis from the SEQUENCE study". Cancer Research 82, n.º 12_Supplement (15 de junio de 2022): 4111. http://dx.doi.org/10.1158/1538-7445.am2022-4111.
Texto completoYap, Timothy A., Arya Ashok, Jessica Stoll, Anna Ewa Schwarzbach, Kimberly L. Blackwell, Tianhong Li, Hyunseok Kang, Judy Ellen Garber y Funda Meric-Bernstam. "Rate of incidental germline findings detected by tumor-normal matched sequencing in cancer types lacking hereditary cancer testing guidelines." Journal of Clinical Oncology 39, n.º 15_suppl (20 de mayo de 2021): 10582. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.10582.
Texto completoVlasenkova, Ramilia, Alsina Nurgalieva, Natalia Akberova, Mikhail Bogdanov y Ramziya Kiyamova. "Characterization of SLC34A2 as a Potential Prognostic Marker of Oncological Diseases". Biomolecules 11, n.º 12 (14 de diciembre de 2021): 1878. http://dx.doi.org/10.3390/biom11121878.
Texto completoAtta, Ihab Shafek y Fahd Nasser AlQahtani. "Thyroid, Renal, and Breast Carcinomas, Chondrosarcoma, Colon Adenomas, and Ganglioneuroma: A New Cancer Syndrome, FAP, or Just Coincidence". Case Reports in Medicine 2016 (2016): 1–5. http://dx.doi.org/10.1155/2016/2928084.
Texto completoHeeke, Arielle Lutterman, Tabari Baker, Filipa Lynce, Michael J. Pishvaian y Claudine Isaacs. "Prevalence of homologous recombination deficiency among all tumor types." Journal of Clinical Oncology 35, n.º 15_suppl (20 de mayo de 2017): 1502. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.1502.
Texto completoBel’skaya, Lyudmila V., Elena A. Sarf, Alexandra I. Loginova, Dmitry M. Vyushkov y En Djun Choi. "Potential Diagnostic Value of Salivary Tumor Markers in Breast, Lung and Ovarian Cancer: A Preliminary Study". Current Issues in Molecular Biology 45, n.º 6 (10 de junio de 2023): 5084–98. http://dx.doi.org/10.3390/cimb45060323.
Texto completoChen, Lifeng, Binbing Ling, Jane Alcorn y Jian Yang. "Quantitative Analysis of the Expression of Human N-myristoyltransferase 1 (hNMT-1) in Cancers". Open Biomarkers Journal 2, n.º 1 (13 de marzo de 2009): 6–10. http://dx.doi.org/10.2174/1875318300902010006.
Texto completoCuriel, Tyler, Suzanne Thibodeaux, Shawna Wall, Sri Lakshmi Pandeswara, Benjamin Daniel, Justin Drerup, Kruthi Murthy, Ilona Kryczek, Weiping Zou y Brian Barnett. "Denileukin diftitox depletes regulatory T cells without clinical benefit in advanced stage epithelial ovarian carcinoma (VAC3P.945)". Journal of Immunology 192, n.º 1_Supplement (1 de mayo de 2014): 73.7. http://dx.doi.org/10.4049/jimmunol.192.supp.73.7.
Texto completoDetopoulou, Paraskevi, George I. Panoutsopoulos, Marina Mantoglou, Periklis Michailidis, Ifigenia Pantazi, Spyros Papadopoulos y Andrea Paola Rojas Gil. "Relation of Mean Platelet Volume (MPV) with Cancer: A Systematic Review with a Focus on Disease Outcome on Twelve Types of Cancer". Current Oncology 30, n.º 3 (14 de marzo de 2023): 3391–420. http://dx.doi.org/10.3390/curroncol30030258.
Texto completoChoi, Eunji, Justin Lee, Julie T. Wu, Heather A. Wakelee, Lidia Schapira, Allison W. Kurian y Summer S. Han. "Abstract P055: Risk factors for second primary lung cancer among breast cancer survivors". Cancer Prevention Research 16, n.º 1_Supplement (1 de enero de 2023): P055. http://dx.doi.org/10.1158/1940-6215.precprev22-p055.
Texto completoSah, Sunil Kumar, Naval Kishor Yadav, Roshan Kurmi, Ramanuj Rauniyar, Krishan Das Manandhar y Birendra Prasad Gupta. "Pattern of Cancer in Nepal from 2003 to 2011". Nepal Journal of Biotechnology 4, n.º 1 (31 de diciembre de 2016): 54–60. http://dx.doi.org/10.3126/njb.v4i1.16348.
Texto completoLindsay, Colin R., Emily C. Shaw, Fiona Blackhall, Kevin G. Blyth, James D. Brenton, Anshuman Chaturvedi, Noel Clarke et al. "Somatic cancer genetics in the UK: real-world data from phase I of the Cancer Research UK Stratified Medicine Programme". ESMO Open 3, n.º 6 (septiembre de 2018): e000408. http://dx.doi.org/10.1136/esmoopen-2018-000408.
Texto completoSun, Ming-Yang, Chia-Lun Chang, Chang-Yun Lu, Szu-Yuan Wu y Jia-Qiang Zhang. "Sarcopenia as an Independent Risk Factor for Specific Cancers: A Propensity Score-Matched Asian Population-Based Cohort Study". Nutrients 14, n.º 9 (2 de mayo de 2022): 1910. http://dx.doi.org/10.3390/nu14091910.
Texto completoMetzen, Marlon, Michael Bruns, Wolfgang Deppert y Udo Schumacher. "Infiltration of Immune Competent Cells into Primary Tumors and Their Surrounding Connective Tissues in Xenograft and Syngeneic Mouse Models". International Journal of Molecular Sciences 22, n.º 8 (19 de abril de 2021): 4213. http://dx.doi.org/10.3390/ijms22084213.
Texto completoKawashiri, Takehiro, Daisuke Kobayashi, Mayako Uchida, Shiori Hiromoto, Masashi Inoue, Hajime Ikeda, Mizuki Inoue y Takao Shimazoe. "Analysis of Secondary Leukemia and Myelodysplastic Syndrome After Chemotherapy for Solid Organ Tumors Using the Food and Drug Administration Adverse Event Reporting System (FAERS)". Journal of Pharmacy & Pharmaceutical Sciences 24 (11 de octubre de 2021): 499–508. http://dx.doi.org/10.18433/jpps31862.
Texto completo